Citation Impact
Citing Papers
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs
2008
Glycation, ageing and carnosine: Are carnivorous diets beneficial?
2005
AGEs and Diabetic Retinopathy
2010
Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster
2013
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
1996 Nature
On the enigma of carnosine’s anti-ageing actions
2008
Advanced Glycation End Products-Induced Gene Expression of Scavenger Receptors in Cultured Human Monocyte-Derived Macrophages
2000
Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells
2003
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Insulin Enhances Macrophage Scavenger Receptor-mediated Endocytic Uptake of Advanced Glycation End Products
1998
Ancient DNA
2001 StandoutNobel
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
2003
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
2002
Hallmarks of aging: An expanding universe
2023 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial Cells
2002
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
2008
How hyperglycemia promotes atherosclerosis: molecular mechanisms
2002
Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis
2001
The AGE‐receptor in the pathogenesis of diabetic complications
2001
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
2010
Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.
1995
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
AGE restriction in diabetes mellitus: a paradigm shift
2011
Restriction of Dietary Glycotoxins Reduces Excessive Advanced Glycation End Products in Renal Failure Patients
2003
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
1997
Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging
1996
A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?
2009
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
2002
Endothelial dysfunction and pathogenesis of diabetic angiopathy
1997
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model
2003
Glucose, glycation and aging
2004
Evidence for Reproductive Isolation between Cave Bear Populations
2004 StandoutNobel
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Endometriosis
2010 Standout
Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice
2002
Diabetes and advanced glycation endproducts
2002
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Maillard reaction indicators in diets usually consumed by adolescent population
2007
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Advanced glycoxidation end products in commonly consumed foods
2004
Atherogenesis and Advanced Glycation: Promotion, Progression, and Preventiona
1997
Advanced glycation end-products: a review
2001 Standout
Morbidity in 565 Type 2 Diabetic Patients According to Stage of Nephropathy
1998
A molecular analysis of ground sloth diet through the last glaciation
2000 StandoutNobel
Diets rich in Maillard reaction products affect protein digestibility in adolescent males aged 11–14 y
2006
Frailty in elderly people
2013 Standout
Immunohistochemical Distribution and Quantitative Biochemical Detection of Advanced Glycation End Products in Fetal to Adult Rats and in Rats with Streptozotocin-Induced Diabetes
2001
Ethnic Disparities in Diabetic Complications in an Insured Population
2002 Standout
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus
2007
A Continuous Glucose Sensor Based on Wired Enzyme ™ Technology - Results from a 3-Day Trial in Patients with Type 1 Diabetes
2003
Physiology and Pathophysiology of Carnosine
2013 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Glycemic Control and Heart Failure Among Adult Patients With Diabetes
2001
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents?
1996
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
2010 Standout
The Free Radical Theory of Aging Matures
1998 Standout
Advanced Glycation End Products
2006 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Benfotiamine Prevents Macro- and Microvascular Endothelial Dysfunction and Oxidative Stress Following a Meal Rich in Advanced Glycation End Products in Individuals With Type 2 Diabetes
2006
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin
2002
Antioxidative and Anti-Glycation Activity of Garcinol fromGarcinia indicaFruit Rind
2000
Molecular Coproscopy: Dung and Diet of the Extinct Ground Sloth Nothrotheriops shastensis
1998 StandoutScienceNobel
Genetic Analyses from Ancient DNA
2004 StandoutNobel
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1
2012
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Oxidative Stress and Diabetic Complications
2010 Standout
Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.
1997
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
2004
Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine.
1995
Polycyclic Polyprenylated Acylphloroglucinols
2006 Standout
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
2000 Standout
Insulin Resistance and Type 2 Diabetes in High-Fat–Fed Mice Are Linked to High Glycotoxin Intake
2005
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.
1992
Mechanisms of Diabetic Complications
2013 Standout
Advanced Glycation Endproducts Promote Adhesion Molecule (VCAM-1, ICAM-1) Expression and Atheroma Formation in Normal Rabbits
1995
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
2002
Oxidative Stress-Inducing Carbonyl Compounds From Common Foods: Novel Mediators of Cellular Dysfunction
2002
Electrochemical Glucose Biosensors
2007 Standout
Electrochemical Glucose Sensors and Their Applications in Diabetes Management
2008 Standout
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
2000 Standout
Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice
2003
Advanced Glycosylation End Products Up-Regulate Connective Tissue Growth Factor (Insulin-Like Growth Factor-Binding Protein-Related Protein 2) in Human Fibroblasts: A Potential Mechanism for Expansion of Extracellular Matrix in Diabetes Mellitus*
2001
Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes
2011
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
2004
High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients
2004
Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1
2009
Insulin Resistance and Atherosclerosis
2006
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Improved Insulin Sensitivity Is Associated With Restricted Intake of Dietary Glycoxidation Products in the db/db Mouse
2002
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
A molecular analysis of dietary diversity for three archaic Native Americans
2001 StandoutNobel
Works of T Koschinsky being referenced
How rapid does blood glucose concentration change in daily-life of patients with Type 1 diabetes?
2002
Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
1994
Presence of Diabetic Complications in Type 1 Diabetic Patients Correlates with Low Expression of Mononuclear Cell AGE-Receptor-1 and Elevated Serum AGE
2001
Increased growth stimulation of human vascular cells by serum from patients with primary hyper-LDL-cholesterolemia
1987
Single Oral Challenge by Advanced Glycation End Products Acutely Impairs Endothelial Function in Diabetic and Nondiabetic Subjects
2007
Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy
1997